The role of glutathione-S-transferase polymorphisms on clinical outcome of ALI/ARDS patient treated with N-acetylcysteine

Respiratory Medicine

Volumn 103, Issue 3, 2009, Pages 434-441

  Moradi, Mandana ^a   Mojtahedzadeh, Mojtaba ^a   Mandegari, Ali ^a,b   Soltan Sharifi, Mohammad Sadegh ^a   Najafi, Atabak ^c   Khajavi, Mohammad Reza ^c   Hajibabayee, Molook ^a   Ghahremani, Mohammad Hossein ^a,d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adult respiratory distress syndrome; Genetic variation; GST; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; PLACEBO;

ACUTE LUNG INJURY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC VARIABILITY; HUMAN; MALE; MORTALITY; OXIDATIVE STRESS; OXYGENATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ACETYLCYSTEINE; ACUTE LUNG INJURY; ADULT; ANTIOXIDANTS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DRUG ADMINISTRATION SCHEDULE; FEMALE; GENE FREQUENCY; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; POLYMORPHISM, GENETIC; RESPIRATORY DISTRESS SYNDROME, ADULT; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 59349087893     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2008.09.013     Document Type: Article

References (46)

1. Weinacker A.B., and Vaszar L.T. Acute respiratory distress syndrome: physiology and new management strategies. Annu Rev Med 52 (2001) 221-237
2. Ware L.B., and Matthay M.A. The acute respiratory distress syndrome. N Engl J Med 342 (2000) 1334-1349
3. Schraufstatter I.U., Revak S.D., and Cochrane C.G. Proteases and oxidants in experimental pulmonary inflammatory injury. J Clin Invest 73 (1984) 1175-1184
4. Bunnell E., and Pacht E.R. Oxidized glutathione is increased in the alveolar fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis 148 (1993) 1174-1178
5. Rahman I., and MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J 16 (2000) 534-554
6. Fialkow L., Chan C.K., Grinstein S., and Downey G.P. Regulation of tyrosine phosphorylation in neutrophils by the NADPH oxidase, role of reactive oxygen intermediates. J Biol Chem 268 (1993) 17131-17137
7. Fialkow L., Chan C.K., Rotin D., Grinstein S., and Downey G.P. Activation of the mitogen-activated protein kinase signaling pathway in neutrophils: role of oxidants. J Biol Chem 269 (1994) 31234-31242
8. Fialkow L., Chan C.K., and Downey G.P. Inhibition of CD45 during neutrophil activation. J Immunol 158 (1997) 5409-5417
9. Gadek J.E., and Pacht E.R. The interdependence of lung antioxidants and antiprotease defense in ARDS. Chest 110 (1996) 273S-277S
10. Haddad J.J., Olver R.E., and Land S.C. Antioxidant/pro-oxidant equilibrium regulates HIF-1alpha and NF-kappa B redox sensitivity: evidence for inhibition by glutathione oxidation in alveolar epithelial cells. J Biol Chem 275 (2000) 21130-21139
11. Baldwin Jr. A.S. Series introduction: the transcription factor NFkappaB and human disease. J Clin Invest 107 (2001) 3-6
12. Comhair S.A., and Erzurum S.C. Antioxidant responses to oxidant-mediated lung diseases. Am J Physiol Lung Cell Mol Physiol 283 (2002) 246-255
13. Honda S., and Matsuo M. Protective effect of glutathione against oxygen-induced growth inhibition of human diploid fibroblasts. Biochem Int 18 (1989) 439-446
14. Kharazmi A., Nielsen H., and Schiotz P.O. N-Acetylcysteine inhibits human neutrophil and monocyte chemotaxis and oxidative metabolism. Int J Immunopharmacol 10 (1988) 39-46
15. Bernard G.R., Lucht W.D., Niedermeyer M.E., Snupper J.R., Oglettree M.L., and Brigham K.L. Effect of N-acetylcysteine on the pulmonary response to endotoxin in the awake sheep and upon in vitro granulocyte function. J Clin Invest 73 (1984) 1772-1784
16. Olsson B., Johansson M., Gabrielsson J., and Bolme P. Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine. Eur J Clin Pharmacol 34 (1988) 77-82
17. Konrad F., Schoenberg M.H., Wiedmann H., Kilian J., and Georgieff M. The application of N-acetylcysteine as an antioxidant and mucolytic in mechanical ventilation in intensive care patients: a prospective, randomized, placebo-controlled, double-blind study. Anaesthesist 44 (1995) 651-658
18. Suter P.M., Dominighetti G., Schaller M.D., Luverriere M.C., Ritz R., and Perret C. N-Acetylcysteine enhances recovery from acute lung injury in man: a randomized, double-blind, placebo-controlled clinical study. Chest 105 (1994) 190-194
19. Domenighetti G., and Suter P.M. Treatment with N-acetylcysteine during acute respiratory distress syndrome: a randomized, double-blind, placebo-controlled clinical study. J Crit Care 12 (1997) 177-182
20. Hayes P.C., Bouchier I.A., and Beckett G.J. Glutathione S-transferase in humans in health and disease. Gut 32 (1991) 813-818
21. Strange R.C., Spiteri M.A., Ramachandran S., and Fryer A.A. Glutathione-S-transferase family of enzymes. Mutat Res 482 (2001) 21-26
22. Parl F.F. Glutathione S-transferase genotypes and cancer risk. Cancer Lett 221 (2005) 123-129
23. Hayesa J.D., and Strangeb R.C. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61 (2000) 154-166
24. Gilliland F.D., Lin Y., Dubeau L., et al. Effects of glutathione S-transferase M1, maternal smoking during pregnancy and environmental tobacco smoke on asthma and wheezing in children. Am J Respir Crit Care Med 166 (2002) 457-463
25. Romieu I., Ramirez-Aguilar M., Sienra-Monge J.J., et al. GSTM1 and GSTP1 and respiratory health in asthmatic children exposed to ozone. Eur Respir J 28 (2006) 953-959
26. Nickel R., Haider A., Sengler C., et al. Association study of glutathione S-transferase P1 (GSTP1) with asthma and bronchial hyper-responsiveness in two German pediatric populations. Pediatr Allergy Immunol 16 (2005) 539-541
27. Cheng S.L., Yu C.J., Chen C.J., et al. Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD. Eur Respir J 23 (2004) 818-824
28. Tomaki M., Sugiura H., Koarai A., et al. Decreased expression of antioxidant enzyme and increased expression of chemokines in COPD lung. Pulm Pharmacol Ther 20 (2007) 596-605
29. Bernard G.R., Artigas A., Briggam K.L., et al. The American-European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149 (1994) 818-824
30. Knaus W.A., Draper E.A., Wagner D.P., and Zimmerman J.E. APACHE II: a severity of disease classification system. Crit Care Med 13 (1985) 818-829
31. Zilberbery M.D., and Epstein S.K. Acute lung injury in the medical ICU: comorbid conditions age, etiology and hospital outcome. Am J Respir Crit Care Med 157 (1998) 1159-1164
32. Abdel-Rahman S.Z., El-Zein R.A., Anwar W.A., and Au W.W. A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies. Cancer Lett 107 (1996) 229-233
33. Bhatia M., and Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 202 (2004) 145-156
34. Ustyuk P.K., Vepa S., Watkins T., He D., Parinandi N.L., and Natarajan V. Redox regulation of reactive oxygen species-induced p38 MAP kinase activation and barrier dysfunction in lung microvascular endothelial cells. Antioxid Redox Signal 5 (2003) 723-730
35. Ortoloni O., Conti A., Degaudio A.R., Masoni M., and Novelli G. Protective effects of N-acetylcysteine and rutin on the lipid peroxidation of the lung epithelium during the adult respiratory distress syndrome. Shock 13 (2000) 14-18
36. Ruffmann R., and Wendell A. GSH rescue by N-acetylcysteine. Klin Wochenschr 69 (1991) 857-862
37. Bernard G.R., Wheeler A.P., Arons M.M., et al. A trial of antioxidant N-acetylcysteine and pro cysteine in ARDS study group. Chest 112 (1997) 164-172
38. Soltan Sharifi S., Mojtahedzadeh M., Najafi A., et al. Improvement by N-acetylcysteine of acute respiratory distress syndrome through increasing intracellular glutathione, and extracellular thiol molecules and anti-oxidant power: evidence for underlying toxicological mechanisms. Hum Exp Toxicol 26 (2007) 697-703
39. Bernard G.R. N-Acetylcysteine in experimental and clinical acute lung injury. Am J Med 30 (1991) 4-59
40. Zhai R., Gong M.N., Zhou W., et al. Genotypes and haplotypes of the VEGF gene are associated with higher mortality and lower VEGF plasma levels in patients with ARDS. Thorax 62 (2007) 718-722
41. Jerng J.S., Yu C.J., Wang H.C., Chen K.Y., Cheng S.L., and Yang P.C. Polymorphism of the angiotensin-converting enzyme gene affects the outcome of acute respiratory distress syndrome. Crit Care Med 34 (2006) 1001-1006
42. Kim Y.J., Park H.S., Park M.H., Suh S.H., and Pang M.G. Oxidative stress related gene polymorphism and the risk of preeclampsia. Eur J Obstet Gynecol Reprod Biol 119 (2005) 42-46
43. Reszka E., Wasowicz W., and Gromadzinska J. Genetic polymorphism of xenobiotic metabolising enzymes, diet and cancer susceptibility. Br J Nutr 96 (2006) 609-619
44. Bolt H.M., and Thier R. Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology. Curr Drug Metab 7 (2006) 613-628
45. Spalletta G., Bernardini S., Bellincampi L., et al. Glutathione S-transferase P1 and T1 gene polymorphisms predict longitudinal course and age at onset of Alzheimer disease. Am J Geriatr Psychiatry 15 (2007) 879-887
46. Imboden M., Rochat T., Brutsche M.H., et al. Glutathione-S transferase genotype increases risk of progression from bronchial hyperresponsiveness to asthma in adults. Thorax 63 (2008) 322-328